|
|
|
|
Research Article
|
|
Malignant Fibrous Histiocytoma Arising from Nasal Cavity |
|
Mohammad Ali Damghani
and
Mohammad Hasan Larizadeh
|
|
|
ABSTRACT
|
The present aim is to report a case of malignant fibrous
histiocytoma of the nasal cavity in a 64-year-old woman. This is a rare
entity in the head and neck region. The patient referred with nasal obstruction
and underwent wide surgical resection with negative margin. He is well
with no evidence of disease for 36 months after surgery.
|
|
|
|
|
|
|
INTRODUCTION
A 64-year old woman presented with a 2 month history of nasal obstruction
and one month history of mild nasal bleeding. Physical examination revealed
a nontender mass in left nasal cavity with pink to red color and ulceration
and crust over its surface. Pressure effect of this mass has been seen
externally. Chest x-Ray was normal. Computed tomographic examination demonstrated
a soft tissue density in left nasal cavity without bone or cartilage invasion
(Fig. 1). Initial clinical diagnosis was pyogenic granuloma.
With this diagnosis, mass excision was done under general anesthesia,
but pathologic study showed the storiform-pleomorphic type of malignant
fibrous histiocytoma (Fig. 2). She underwent re-operation
for obtaining safe margins. There has been no evidence of local recurrence
or distant metastasis for 36 months following the final surgery.
Soft Tissue Sarcomas (STS) are rare solid tumors accounting for less
than 1% of all malignancies and are very unusual in the head and neck
region (Pandey et al., 2003). Three percent to 10% of all MFHs
occur in the head and neck and MFH constitutes approximately 5% of head
and neck sarcomas (Leon and Amal, 1988; Philip et al., 2003). In
a patients group reported by Sabesan and his colleagues, nasal cavity
accounted for 3 of 54 MFH (6%), arisen from head and neck region (Sabesan
et al., 2006). In another series, ethmoid sinus and nasal cavity
accounted for 1 of 12 MFH, arisen from head and neck (Leon and Amal, 1988).
Another report mentioned that 3 out of 22 cases (13.6%) of STS of the
head and neck were MFH. However, none of the reported cases occurred in
nasal cavity (Pandey et al., 2003). For patient with resectable
STS, wide local excision with optimal margins of normal tissue represents
the primary modality of treatment (Philip et al., 2003; Nicolas
et al., 2004). In most sarcomas involving the nose, the surgical
procedures employed do not significantly differ from those used for other
malignancies of this region. Rhinectomy with palatectomy and possibly
maxillectomy/ethmoidectomy may be required for obtaining wide margin (Philip
et al., 2003). Unlike extremity sarcomas, head and neck sarcomas
usually are not amenable to wide resection with generous margins .The
use of adjuvant radiation is more liberal in this site. Post-operative
radiotherapy may be used in the following conditions: high-grade lesions
and/or positive surgical margins, lesions larger than 5 cm and recurrent
lesions (Philip et al., 2003). Little is known about prognostic
factors and treatment results of MFHs of the head and neck (Nicolas et
al., 2004). Literature data shows that 20 to 42% of individuals with
MFHs of the head and neck
 |
Fig. 1: |
Preoperative coronal CT Scan showing nasal cavity mass |
 |
Fig. 2: |
MFH, plump and spindle cells arranged in short fascicles
in storiform pattern around small vessels. (HandE, x100) |
will experience local recurrence due to difficulties to obtain wide resection.
At least 25 to 35% of these patients will develop systemic metastases,
most often to the lung. The overall 5-year survival has been reported
to be between 25 and 60% (Leon and Amal, 1988; Sabesan et al.,
2006). We did not use adjuvant treatment in this case and she is alive
with no evidence of recurrence after 36 months from the last surgery.
|
REFERENCES |
Leon, B. and K. Amal, 1988. Malignant fibrous histiocytoma of the head and Neck: A report of 12 cases. Arch. Otolaryngol. Head Neck Surg., 114: 1149-1156. PubMed |
Nicolas, P., V.H. Christophe, L. Eric, V. Marie-Odile, T.V. Jean, M. Yann and L. Jean-Louis, 2004. Head and neck soft tissue sarcomas of adult: Prognostic value of surgery in multimodal therapeutic approach. Oral. Oncol., 40: 890-897. Direct Link |
Pandey, M., K. Chandramohan, G. Thomas, A. Mathew and E.K. Abraham et al., 2003. Soft tissue sarcoma of the head and neck region in adults. Int. J. Oral. Surg., 32: 43-48. CrossRef |
Philip, K., F. Alfio, J. Patrick, R. Ashok and R. Alessandra, 2003. Management of sarcomas of the head and neck in adults. Oral. Oncol., 39: 2-12. CrossRef |
Sabesan, T., W. Xuexi, Q. Yongfa, T. Pingzhang and V. Ilankovan, 2006. Malignant fibrous histiocytoma: Outcome of tumours in the head and neck compared with those in the trunk and extremities. Br. J. Oral. Maxillofac. Surg., 44: 209-212. Direct Link |
|
|
|
 |